MRNA Jun 2024 167.500 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 11:56AM EDT. Market open.
| Previous close | 0.0300 |
| Open | 0.1000 |
| Bid | 0.0000 |
| Ask | 0.0100 |
| Strike | 167.50 |
| Expiry date | 2024-06-28 |
| Day's range | 0.1000 - 0.1000 |
| Contract range | N/A |
| Volume | |
| Open interest | 59 |
ZacksCDC Narrows Age Recommendation for Use of RSV Vaccine
The U.S. CDC recommends that adults aged 75 years and above get an RSV shot. Those aged 60 to 74 years should only get the shot if they are at high risk for severe RSV due to chronic conditions.
ZacksPfizer (PFE), BioNTech's Updated COVID-19 Jab Gets CHMP Nod
Pfizer (PFE) and BioNTech's Omicron JN.1-adapted COVID-19 vaccine gets the Committee for Medicinal Products for Human Use's positive opinion recommending marketing authorization.
ZacksModerna (MRNA) Shares Decline on RSV Vaccine Efficacy Data
Moderna (MRNA) stock sinks after new data shows the efficacy of its mRNA-based RSV vaccine fell sharply in the second year and was lower than that of rival vaccines marketed by GSK and Pfizer.
© 2024 Yahoo. All rights reserved.